887425-47-0

Basic information

• Product Name: 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL
• Synonyms: 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL;1-(5-BROMOPYRIMIDIN-2-YL)PIPERIDIN-4-OL;1-(5-bromo-2-pyrimidinyl)-4-piperidinol
• CAS NO: 887425-47-0
• Molecular Formula: C₉H₁₂BrN₃O
• Molecular Weight: 258.12
• Mol File: 887425-47-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 418.5 °C at 760 mmHg
• Flash Point: 206.9 °C
• Appearance: /
• Density: 1.6g/cm³
• Vapor Pressure: 9.42E-08mmHg at 25°C
• Refractive Index: 1.618
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL(887425-47-0)
• EPA Substance Registry System: 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL(887425-47-0)

Safety Data

• Hazardous Substances Data: 887425-47-0(Hazardous Substances Data)

Usage

General Description

1-(5-Bromopyrimidin-2-yl)-4-piperidinol is a chemical compound that belongs to the class of piperidinols and contains a bromopyrimidine group. It is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. Its molecular structure consists of a piperidine ring with a hydroxyl group and a bromopyrimidine moiety attached to it. 1-(5-BROMOPYRIMIDIN-2-YL)-4-PIPERIDINOL has potential applications in medicinal chemistry and drug discovery due to its diverse reactivity and pharmacological properties. It is also used as a reagent in organic synthesis for the creation of heterocyclic compounds. Overall, 1-(5-Bromopyrimidin-2-yl)-4-piperidinol is an important synthetic intermediate with promising applications in various fields.

InChI:InChI=1/C9H12BrN3O/c10-7-5-11-9(12-6-7)13-3-1-8(14)2-4-13/h5-6,8,14H,1-4H2

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 32779-36-5 5-Bromo-2-chloropyrimidine 

Downstream Products

• 1279030-58-8 tert-butyl {2-[{3-[2-(4-hydroxypiperidin-1-yl)pyrimidin-5-yl]benzyl}(methyl)amino]-2-oxoethyl}carbamate 

Relevant articles and documents

BRAF DEGRADERS

Present invention provides compounds that cause specifically the degradation of BRAF. The present compounds are useful for the treatment of various cancers.

NOVEL COMPOUNDS AS DUAL INHIBITORS OF PHOSPHODIESTERASES AND HISTONE DEACETYLASES

It relates to certain compounds having a polycyclic structure and a hydroxamic acid moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to a process for their preparation, as well as to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neurodegenerative diseases. wherein B1 is a radical selected from the group consisting of formula (A"), formula (B"), formula (C"), and formula (D"):

GPR119 AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.